This week California-based biotech firm Amgen released Amjevita, the first close copy of the best selling drug of all time. At least seven more Humira biosimilars are expected to debut later this year.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
